Jabodon Pt CO Pacira Bio Sciences, Inc. Transaction History

Jabodon Pt CO

  • $81.2 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 12, 2022
SELL
$60.03 - $76.49 $120,540 - $153,591
-2,008 Reduced 3.93%
49,052 $3.74 Million
Q4 2021

Feb 14, 2022
SELL
$47.97 - $62.21 $1.05 Million - $1.36 Million
-21,792 Reduced 29.91%
51,060 $3.07 Million
Q3 2021

Oct 27, 2021
BUY
$54.64 - $61.3 $3.98 Million - $4.47 Million
72,852 New
72,852 $4.08 Million

Others Institutions Holding PCRX

# of Institutions
263
Shares Held
50.4M
Call Options Held
429K
Put Options Held
391K
View Full List

About Pacira BioSciences, Inc.

PCRX Quotes by TradingView
  • Ticker PCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 45,824,200
  • Market Cap $892M
  • Description
  • Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...
More about PCRX
Track This Portfolio

Track Jabodon Pt CO Portfolio

Follow Jabodon Pt CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jabodon Pt CO, based on Form 13F filings with the SEC.

News

Stay updated on Jabodon Pt CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email